These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11688965)

  • 61. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone.
    Crain SM; Shen KF
    Brain Res; 2008 Sep; 1231():16-24. PubMed ID: 18656459
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Novel, Pan-PDE Inhibitor Exerts Anti-Fibrotic Effects in Human Lung Fibroblasts via Inhibition of TGF-β Signaling and Activation of cAMP/PKA Signaling.
    Wójcik-Pszczoła K; Chłoń-Rzepa G; Jankowska A; Ślusarczyk M; Ferdek PE; Kusiak AA; Świerczek A; Pociecha K; Koczurkiewicz-Adamczyk P; Wyska E; Pękala E; Gosens R
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503342
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 64. PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP.
    Lee R; Wolda S; Moon E; Esselstyn J; Hertel C; Lerner A
    Cell Signal; 2002 Mar; 14(3):277-84. PubMed ID: 11812656
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ethanol increases phosphodiesterase 4 activity in bovine bronchial epithelial cells.
    Forgèt MA; Sisson JH; Spurzem JR; Wyatt TA
    Alcohol; 2003; 31(1-2):31-8. PubMed ID: 14615009
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors.
    Méhats C; Tanguy G; Paris B; Robert B; Pernin N; Ferré F; Leroy MJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):817-23. PubMed ID: 10640323
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Type IV phosphodiesterase inhibitor suppresses insulin-dependent myocardial glucose uptake.
    Imahashi K; Yoshioka J; Yamakita T; Yamano S; Kusuoka H; Nishimura T
    Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):290-1. PubMed ID: 11251642
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function.
    Miller AH; Vogt GJ; Pearce BD
    Neuropsychopharmacology; 2002 Dec; 27(6):939-48. PubMed ID: 12464451
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
    Barnette MS; Manning CD; Price WJ; Barone FC
    J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
    Bode DC; Hamel LT; Wax MB
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
    Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
    Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Visual detection of AMP and real-time monitoring of cyclic nucleotide phosphodiesterase (PDE) activity in neutral aqueous solution. Chemosensor-coupled assay of PDE and PDE inhibitors.
    Han MS; Kim DH
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1079-82. PubMed ID: 12643916
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues.
    Kenk M; Greene M; Thackeray J; deKemp RA; Lortie M; Thorn S; Beanlands RS; DaSilva JN
    Nucl Med Biol; 2007 Jan; 34(1):71-7. PubMed ID: 17210463
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
    Ellis JL; Conanan ND
    J Pharmacol Exp Ther; 1995 Mar; 272(3):997-1004. PubMed ID: 7891355
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phosphodiesterase 3 as a potential target for therapy of malignant tumors in the submandibular gland.
    Murata T; Sugatani T; Shimizu K; Manganiello VC; Tagawa T
    Anticancer Drugs; 2001 Jan; 12(1):79-83. PubMed ID: 11272291
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of cyclic nucleotide phosphodiesterase isoforms associated to isolated cardiac nuclei.
    Lugnier C; Keravis T; Le Bec A; Pauvert O; Proteau S; Rousseau E
    Biochim Biophys Acta; 1999 Nov; 1472(3):431-46. PubMed ID: 10564757
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
    Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE
    Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.
    Souness JE; Maslen C; Webber S; Foster M; Raeburn D; Palfreyman MN; Ashton MJ; Karlsson JA
    Br J Pharmacol; 1995 May; 115(1):39-46. PubMed ID: 7647982
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors.
    Palmer D; Tsoi K; Maurice DH
    Circ Res; 1998 May; 82(8):852-61. PubMed ID: 9576105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.